Coaptite – Enrollment Closed

A post –approval study to assess the long term safety and effectiveness Coaptite for the treatment of female urinary incontinence.

Inclusion Criteria:

  • Has female urinary stress incontinence that is due to intrinsic sphincter deficiency
  • Has a baseline pas weight of >50 grams
  • Age > 18 years
  • Has a viable mucosal lining at likely site of injection (bladder neck)